
-
Nine killed in Russian drone attack on Ukraine after talks
-
Canberra slams Russian jailing of Australian who fought for Ukraine
-
S. Korea's ex-president Yoon leaves party ahead of snap election
-
Rescuers say 100 dead as Israel launches fresh Gaza offensive
-
Arab League to meet in Baghdad to discuss regional crises
-
'Alpha predator' sharks and humans clash on an Israeli beach
-
Lights, cameras, action at Eurovision Song Contest final
-
Crusaders hail O'Connor as Wallabies trump card in Lions series
-
Musk's xAI blames 'unauthorized' tweak for 'white genocide' posts
-
Sean 'Diddy' Combs trial: Takeaways from first week of testimony
-
What to Consider When Applying for Personal Loans in Baton Rouge
-
Manhunt in US tourist hub New Orleans after 10 escape jail
-
Vegas clings to PGA lead as Kim, Scheffler charge
-
US loses last triple-A credit rating as Moody's cuts over govt debt
-
Trump blasts Supreme Court over block on deportations
-
US loses last triple-A credit rating as Moody's cuts on growing govt debt
-
Lyon win fourth French women's crown in a row
-
Joaquin Phoenix stars in Covid-era thriller set in 'sick' America
-
US Supreme Court blocks Trump bid to resume Venezuelan deportations
-
Arteta ready to smash Arsenal transfer budget to sign striker
-
Combs's ex Cassie wraps grim week of testimony
-
Trump reshapes US Mideast policy. Can deals work instead?
-
US approves first blood test for Alzheimer's
-
Vegas hits the jackpot with surge to the top at PGA
-
Cucurella steers Chelsea towards the Champions League in Man Utd win
-
Sinner lines up Alcaraz showdown in Italian Open final
-
US stocks add to weekly gains amid trade deal optimism
-
Sinner reaches Italian Open final and Alcaraz showdown
-
US considering reality TV competition for citizenship
-
France's Pavon delivers career major low 65 to contend at PGA
-
Villa sink Spurs to bolster bid to reach Champions League
-
Extra work, new caddie has Homa achieving major feats at PGA
-
Gaza rescuers say Israeli strikes kill 100 as Hamas makes a plea to lift blockade
-
Salah slams 'harsh' Liverpool fans for jeering Alexander-Arnold
-
Vegas closes with double bogey but still leads by two at PGA
-
US Fed plans to cut workforce by 10% in next 'couple of years'
-
European leaders seek united front with Trump on Ukraine
-
NWSL says should have stopped game after King collapse
-
Ravers revel in Cannes spotlight with thumping 'Sirat'
-
'Fortnite' unavailable on Apple devices worldwide
-
Combs's ex Cassie takes witness stand for fourth day
-
Fraser-Pryce beaten by Jamaican starlet Tia Clayton in Doha
-
Ayuso climbs to Giro stage seven win, Roglic takes overall lead
-
EU tech chief urges US cooperation as key decisions near
-
UN rights chief warns of 'ethnic cleansing' in Gaza
-
Piastri beats Norris again in McLaren's second 1-2 in practice at Imola
-
ICC prosecutor, under investigation, steps aside temporarily
-
German female-led 'folk-horror' early favourite in Cannes
-
Gaza rescuers say Israeli strikes kill 88 as Hamas makes a plea to lift blockade
-
Trump family hotel project in Serbia in doubt after forgery probe

US Supreme Court asked to lift restrictions on abortion pill
The manufacturer of a widely used abortion pill asked the US Supreme Court on Friday to toss out a lower court ruling that would restrict access to the drug.
A US federal appeals court imposed restrictions last month on mifepristone but the ruling was put on hold pending an appeal to the Supreme Court.
Danco Laboratories, which markets mifepristone under the brand name Mifeprex, formally asked the nation's highest court on Friday to take up the case.
The Justice Department is expected to file a brief supporting Danco's request for the Supreme Court to review the ruling by the lower court.
Last month's ruling by a three-judge panel of the New Orleans-based 5th Circuit Court of Appeals would limit the use of mifepristone to the first seven weeks of pregnancy, instead of the current 10, and block it from being distributed by mail.
It would also require the abortion pill, which accounts for more than half of the abortions in the United States, to be prescribed by a doctor.
Anti-abortion groups are seeking to have mifepristone banned, claiming despite its long track record that it is unsafe. The case is the latest skirmish in the battle over reproductive rights in the United States.
The appeals court panel said the Food and Drug Administration (FDA), which approved the abortion pill in 2000 and made it more readily available in 2016, "failed to address several important concerns about whether the drug would be safe for the women who use it."
At a hearing in May, the judges pushed back against government arguments that the decision on whether to allow the use of mifepristone should be left to the FDA.
In its brief to the Supreme Court, Danco said the 5th Circuit ruling "upends FDA-approved conditions of use for Danco's drug Mifeprex.
"It does so at the request of a group of plaintiffs who do not prescribe or use the drug and whose real disagreement with FDA is that they oppose all forms of abortion," Danco said.
The case stems from an earlier ruling by a conservative US District Court judge in Texas that would have banned mifepristone.
The 5th Circuit blocked a ban on the abortion pill, but imposed the restrictions on access.
Conservatives wield a 6-3 majority on the Supreme Court, which overturned the constitutional right to abortion in a landmark ruling in June of last year.
Since then, some 20 states, mostly in the South and the Midwest, have prohibited abortion outright or restricted access while others, mainly on the coasts, have moved to protect it.
The FDA estimates that 5.6 million Americans have used mifepristone to terminate pregnancies since it was approved in 2000.
D.Kaufman--AMWN